Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups

Author:

Würnschimmel Christoph12,Wenzel Mike23,Collà Ruvolo Claudia24,Nocera Luigi25,Tian Zhe2,Saad Fred2,Briganti Alberto5,Shariat Shahrokh F678910,Mirone Vincenzo4,Chun Felix KH3,Tilki Derya111,Graefen Markus1,Karakiewicz Pierre I2

Affiliation:

1. Martini‐Klinik Prostate Cancer Center University Hospital Hamburg‐Eppendorf Hamburg Germany

2. Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montréal Health Center Montréal Quebec Canada

3. Department of Urology University Hospital Frankfurt Frankfurt Germany

4. Department of Neurosciences, Reproductive Sciences and Odontostomatology University of Naples Federico II NaplesItaly

5. Department of Urology and Division of Experimental Oncology Urological Research Institute IBCAS San Raffaele Scientific Institute Milan Italy

6. Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria

7. Department of Urology Weill Cornell Medical College New York New YorkUSA

8. Department of Urology University of Texas Southwestern Dallas Texas USA

9. Department of Urology Second Faculty of Medicine Charles University Prague Czech Republic

10. Institute for Urology and Reproductive Health I.M. Sechenov First Moscow State Medical University Moscow Russia

11. Department of Urology University Hospital Hamburg‐Eppendorf Hamburg Germany

Publisher

Wiley

Subject

Urology

Reference25 articles.

1. No improvement noted in overall or cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period

2. National Comprehensive Cancer Network. Clinical Practice Guidelines on Prostate Cancer(Version 2.2020 — May 21 2020). [Cited 23 Mar 2021]. Available from URL:https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf

3. Social Security Administration. Actuarial Life Tables(Period Life Table 2017). [Cited 23 Mar 2021]. Available from URL:https://www.ssa.gov/OACT/STATS/table4c6.html

4. Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer

5. The incidence, mortality, and risk factors of prostate cancer in Asian men

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3